Company patents

Cardio Flow, Inc.

Cardio Flow, Inc. exhibits a highly concentrated patent strategy, with 100% of its 50 patents in Medical Diagnostics & Surgery, which surprisingly saw a significant 30.8% growth in 2025 after a decline, though patenting so far in 2026 is down 70.6%. The company's minor interest in Drug Delivery Devices, representing only 6.0% of its portfolio, appears to be a shifting priority given its 100% year-over-year decline in 2024 and again so far in 2026.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

50 US filings (since 2023) · 2 categories · 2 themes

Patents

Showing 41-50 of 140

Page 5 of 14
145614